Biohit Oyj
OMXH:BIOBV
Wall Street
Price Targets
BIOBV Price Targets Summary
Biohit Oyj
According to Wall Street analysts, the average 1-year price target for BIOBV is 3.57 EUR with a low forecast of 3.54 EUR and a high forecast of 3.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIOBV's stock price target?
Price Target
3.57
EUR
According to Wall Street analysts, the average 1-year price target for BIOBV is 3.57 EUR with a low forecast of 3.54 EUR and a high forecast of 3.68 EUR.
What is Biohit Oyj's Revenue forecast?
Projected CAGR
17%
For the last 14 years the compound annual growth rate for Biohit Oyj's revenue is 15%. The projected CAGR for the next 3 years is 17%.
What is Biohit Oyj's Operating Income forecast?
Projected CAGR
12%
The compound annual growth rate of Biohit Oyj's operating income for the next 3 years is 12%.
What is Biohit Oyj's Net Income forecast?
Projected CAGR
10%
For the last 14 years the compound annual growth rate for Biohit Oyj's net income is -17%. The projected CAGR for the next 3 years is 10%.
